Advertisement
Screener

AdaptHealth Corp. (AHCO) Net Income (Loss) Available to Common Stockholders, Basic

2.8 / 5 stars · 68/120 Roast Me

AdaptHealth Corp. Net Income (Loss) Available to Common Stockholders, Basic

AdaptHealth Corp. (AHCO) reported Net Income (Loss) Available to Common Stockholders, Basic of -$16.04 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-05-05

  • AdaptHealth Corp. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$16.04M.
  • AdaptHealth Corp. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$100.08M, a 317.56% decline year-over-year.
  • AdaptHealth Corp. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was $22.45M, a 7.29% increase year-over-year.
  • AdaptHealth Corp. net income (loss) available to common stockholders, basic for the quarter ending 2025-06-30 was $13.44M, a 24.41% decline year-over-year.
  • AdaptHealth Corp. net income (loss) available to common stockholders, basic for fiscal 2025 was -$70.79M, a 185.55% decline from fiscal 2024.
  • AdaptHealth Corp. net income (loss) available to common stockholders, basic for fiscal 2024 was $82.75M.
  • AdaptHealth Corp. net income (loss) available to common stockholders, basic for fiscal 2023 was -$678.89M, a 1169.99% decline from fiscal 2022.
  • AdaptHealth Corp. net income (loss) available to common stockholders, basic for fiscal 2022 was $63.45M, a 55.25% decline from fiscal 2021.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 3 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 6 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 9 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 12 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month as first filed
2026-03-31-$16.04M
10-Q · filed 2026-05-05
-$116.12M
derived: sum of 2 quarters · filed 2026-05-05
-$93.67M
derived: sum of 3 quarters · filed 2026-05-05
-$80.23M
derived: sum of 4 quarters · filed 2026-05-05
2025-12-31-$100.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$77.63M
derived: sum of 2 quarters · filed 2026-02-24
-$64.19M
derived: sum of 3 quarters · filed 2026-02-24
-$70.79M
10-K · filed 2026-02-24
2025-09-30$22.45M
10-Q · filed 2025-11-04
$35.89M
derived: sum of 2 quarters · filed 2025-11-04
$29.29M
10-Q · filed 2025-11-04
$74.69M
derived: sum of 4 quarters · filed 2026-05-05
2025-06-30$13.44M
10-Q · filed 2025-08-05
$6.84M
10-Q · filed 2025-08-05
$52.23M
derived: sum of 3 quarters · filed 2026-05-05
$73.16M
derived: sum of 4 quarters · filed 2026-05-05
2025-03-31-$7.21M
10-Q · filed 2026-05-05
$38.80M
derived: sum of 2 quarters · filed 2026-05-05
$59.72M
derived: sum of 3 quarters · filed 2026-05-05
$77.50M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$46.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$66.93M
derived: sum of 2 quarters · filed 2026-02-24
$84.71M
derived: sum of 3 quarters · filed 2026-02-24
$82.75M
10-K · filed 2026-02-24
2024-09-30$20.93M
10-Q · filed 2025-11-04
$38.70M
derived: sum of 2 quarters · filed 2025-11-04
$36.74M
10-Q · filed 2025-11-04
-$217.93M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$17.78M
10-Q · filed 2025-08-05
$15.83M
10-Q · filed 2025-08-05
-$238.86M
derived: sum of 3 quarters · filed 2026-02-24
-$692.93M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31-$2.13M
10-Q · filed 2025-05-06
-$256.64M
derived: sum of 2 quarters · filed 2026-02-24
-$710.71M
derived: sum of 3 quarters · filed 2026-02-24
-$697.92M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$254.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$708.58M
derived: sum of 2 quarters · filed 2026-02-24
-$695.78M
derived: sum of 3 quarters · filed 2026-02-24
-$678.89M
10-K · filed 2026-02-24
2023-09-30-$454.08M
10-Q · filed 2024-11-05
-$441.28M
derived: sum of 2 quarters · filed 2024-11-05
-$424.39M
10-Q · filed 2024-11-05
-$429.28M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$12.79M
10-Q · filed 2024-08-06
$27.18M
10-Q · filed 2024-08-06
$24.80M
derived: sum of 3 quarters · filed 2025-02-25
$39.56M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$14.38M
10-Q · filed 2024-05-07
$12.00M
derived: sum of 2 quarters · filed 2025-02-25
$26.77M
derived: sum of 3 quarters · filed 2025-02-25
$39.61M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31-$2.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$12.39M
derived: sum of 2 quarters · filed 2025-02-25
$25.23M
derived: sum of 3 quarters · filed 2025-02-25
$63.45M
10-K · filed 2025-02-25
2022-09-30$14.76M
10-Q · filed 2023-11-07
$27.61M
derived: sum of 2 quarters · filed 2023-11-07
$65.83M
10-Q · filed 2023-11-07
$86.96M
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30$12.85M
10-Q · filed 2023-08-08
$51.06M
10-Q · filed 2023-08-08
$72.19M
derived: sum of 3 quarters · filed 2024-02-27
$125.28M
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31$38.21M
10-Q · filed 2023-05-09
$59.35M
derived: sum of 2 quarters · filed 2024-02-27
$112.44M
derived: sum of 3 quarters · filed 2024-02-27
$184.64M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$21.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$74.22M
derived: sum of 2 quarters · filed 2024-02-27
$146.42M
derived: sum of 3 quarters · filed 2024-02-27
$141.80M
10-K · filed 2024-02-27
2021-09-30$53.09M
10-Q · filed 2022-11-08
$125.29M
derived: sum of 2 quarters · filed 2022-11-08
$120.66M
10-Q · filed 2022-11-08
$40.81M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$72.20M
10-Q · filed 2022-08-09
$67.71M
10-Q · filed 2022-08-09
-$12.28M
derived: sum of 3 quarters · filed 2023-02-28
-$63.32M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$3.97M
10-Q · filed 2022-05-10
-$84.48M
derived: sum of 2 quarters · filed 2023-02-28
-$135.52M
derived: sum of 3 quarters · filed 2023-02-28
-$131.17M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$80.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$131.55M
derived: sum of 2 quarters · filed 2023-02-28
-$127.20M
derived: sum of 3 quarters · filed 2023-02-28
-$161.63M
10-K · filed 2023-02-28
-$64.48M
10-K · filed 2021-03-16
2020-09-30-$51.03M
10-Q · filed 2021-11-09
-$2.49M
10-Q · filed 2020-11-06
-$46.68M
derived: sum of 2 quarters · filed 2021-11-09
-$81.12M
10-Q · filed 2021-11-09
$1.20M
10-Q · filed 2020-11-06
-$91.01M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$4.35M
10-Q · filed 2021-08-06
$4.03M
10-Q · filed 2020-08-07
-$30.08M
10-Q · filed 2021-08-06
$3.88M
10-Q · filed 2020-08-07
-$39.97M
derived: sum of 3 quarters · filed 2022-03-01
-$43.66M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$34.55M
10-Q · filed 2021-05-10
-$44.32M
derived: sum of 2 quarters · filed 2022-03-01
-$48.01M
derived: sum of 3 quarters · filed 2022-03-01
-$50.09M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$9.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$13.46M
derived: sum of 2 quarters · filed 2022-03-01
-$15.54M
derived: sum of 3 quarters · filed 2022-03-01
-$21.34M
10-K · filed 2022-03-01
-$17.06M
10-K · filed 2021-03-16
2019-09-30-$3.69M
10-Q · filed 2020-11-06
-$5.77M
derived: sum of 2 quarters · filed 2020-11-06
-$11.57M
10-Q · filed 2020-11-06
2019-06-30-$2.08M
10-Q · filed 2020-08-07
-$7.88M
10-Q · filed 2020-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Addus HomeCare Corp (ADUS)United States$2.129B17.80
Aveanna Healthcare Holdings, Inc. (AVAH)United States$2.703B7.22
Option Care Health, Inc. (OPCH)United States$3.602B20.52
CHEMED CORP (CHE)United States$6.474B22.14
BrightSpring Health Services, Inc. (BTSG)United States$11.078B37.65